GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.

Saved in:
Bibliographic Details
Title: GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.
Authors: Kweekel, D M1 d.m.kweekel@lumc.nl, Koopman, M2, Antonini, N F3, Van der Straaten, T1, Nortier, J W R4, Gelderblom, H4, Punt, C J A2, Guchelaar, H-J1
Source: British Journal of Cancer. 10/21/2008, Vol. 99 Issue 8, p1316-1321. 6p. 3 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6604654